Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Borderline hypertension.

S Julius1

  • 1Department of Internal Medicine, University of Michigan Medical School, Ann Arbor, 48109-0356, USA.

Clinical and Experimental Hypertension (New York, N.Y. : 1993)
|July 28, 1999
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Lowering Albuminuria-Does It Lower the Cardiovascular Risk?: Reduction in Albuminuria Translates to Reduction in Cardiovascular Events in Hypertensive Patients: Losartan Intervention for Endpoint Reduction in Hypertension Study. Hypertension 45: 198-202, 2005.

Journal of the American Society of Nephrology : JASN·2023
Same author

Reducing Microalbuminuria-Does It Lower Cardiovascular Risk?: Reduction in Albuminuria Translates to Reduction in Cardiovascular Events in Hypertensive Patients: Losartan Intervention for Endpoint Reduction in Hypertension Study. Hypertension 45: 198-202, 2005.

Journal of the American Society of Nephrology : JASN·2023
Same author

AGRICULTURAL BEST MANAGEMENT PRACTICE SENSITIVITY TO CHANGING AIR TEMPERATURE AND PRECIPITATION.

Transactions of the ASABE·2021
Same author

Toward indicators of the performance of US Infrastructures under climate change risks.

Climatic change·2021
Same author

Namaqualand hip dysplasia in South Africa: The molecular determinant elucidated.

South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde·2021
Same author

Relationships between metrics of visit-to-visit variability of blood pressure.

Journal of human hypertension·2013
Same journal

Adiponectin improves the aortic dissection by inhibiting inflammatory cell infiltration and macrophage pyroptosis.

Clinical and experimental hypertension (New York, N.Y. : 1993)·2026
Same journal

Electroacupuncture for essential hypertension: Mechanistic insights, current clinical evidence, and translational challenges.

Clinical and experimental hypertension (New York, N.Y. : 1993)·2026
Same journal

Association of intracranial atherosclerotic stenosis with 1-year cognitive impairment after acute ischemic stroke or transient ischemic attack: a nationwide prospective cohort study.

Clinical and experimental hypertension (New York, N.Y. : 1993)·2026
Same journal

Frailty as a mediator of the association between hyperuricemia and stroke risk: A prospective cohort study.

Clinical and experimental hypertension (New York, N.Y. : 1993)·2026
Same journal

Synergistic impact of nondipper heart rate and blood pressure on left ventricular hypertrophy in essential hypertension.

Clinical and experimental hypertension (New York, N.Y. : 1993)·2026
Same journal

From clinic to home monitoring: Diagnostic strategies and evidence landscape of white-coat uncontrolled hypertension.

Clinical and experimental hypertension (New York, N.Y. : 1993)·2026
See all related articles

Borderline hypertension, a common condition, significantly impacts cardiovascular health. Initial management involves nonpharmacologic treatment, with medication considered if blood pressure remains high.

Area of Science:

  • Cardiology
  • Hypertension Research
  • Preventive Medicine

Background:

  • Borderline hypertension is prevalent and linked to increased cardiovascular mortality.
  • Associated rheologic, hemodynamic, humoral, and metabolic abnormalities contribute to coronary risk.
  • Existing literature lacks a clear management and treatment algorithm.

Purpose of the Study:

  • To outline a management strategy for borderline hypertension.
  • To emphasize the importance of accurate blood pressure assessment.
  • To guide therapeutic decisions based on treatment response and patient factors.

Main Methods:

  • Establishing a reliable baseline blood pressure using ambulatory or home monitoring.
  • Recommending one year of intensive nonpharmacologic treatment as the initial approach.

Related Experiment Videos

  • Considering pharmacologic treatment with low-dose antihypertensives if nonpharmacologic methods fail.

    • Main Results:

    • Accurate baseline blood pressure measurement is crucial for management.
    • Nonpharmacologic treatment is the recommended first-line therapy for one year.
    • Pharmacologic intervention is reserved for persistent hypertension, especially with dyslipidemia.

    Conclusions:

    • A structured approach to borderline hypertension management is necessary.
    • Nonpharmacologic interventions should be prioritized.
    • Pharmacologic treatment should be carefully considered based on individual patient profiles and treatment outcomes.